Loading…
Guardian Pharmacy Services, Inc. is projected to rise to $58.19 by 2027, a +42% move from its current price of $40.96. GRDN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $40.06 | $40.98 | $41.93 | +0.06% |
| Jul 14 | $39.70 | $41.01 | $42.36 | +0.12% |
| Jul 15 | $39.44 | $41.03 | $42.69 | +0.18% |
| Jul 16 | $39.22 | $41.06 | $42.98 | +0.24% |
| Jul 17 | $39.03 | $41.08 | $43.24 | +0.30% |
| Jul 18 | $38.87 | $41.11 | $43.48 | +0.36% |
| Jul 19 | $38.71 | $41.13 | $43.70 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $38.71 | $41.13 | $43.70 | +0.42% |
| Week 2 | $37.91 | $41.31 | $45.00 | +0.84% |
| Week 3 | $37.35 | $41.48 | $46.07 | +1.27% |
| Week 4 | $36.90 | $41.65 | $47.02 | +1.69% |
| Week 5 | $36.53 | $41.83 | $47.90 | +2.12% |
| Week 6 | $36.21 | $42.01 | $48.73 | +2.55% |
| Week 7 | $35.93 | $42.18 | $49.52 | +2.98% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Guardian Pharmacy Services, Inc. is a healthcare company that provides a suite of technology-enabled pharmacy services to help residents of long-term health care facilities (LTCFs) in the United States.
Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs.
Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
Guardian Pharmacy Services, Inc. (GRDN) is a healthcare company with a current price of $42.31 and a market cap of $2.68B. It is ranked 1837 by market capitalization.
The asset is categorized in Healthcare.
The price outlook shown in the forecast indicates a bullish trajectory through 2050. The 2026 average price is $42.31 with ROI 0 and sentiment Neutral. The forecast progresses to a 2027 average of $60.20 (ROI 42.3, bullish), 2028 average $73.35 (ROI 73.4, bullish), and 2029 average $78.12 (ROI 84.6, bullish).
By 2030, the average is $91.57 (ROI 116.4, bullish); 2031 $111.33 (ROI 163.1); 2032 $135.34 (ROI 219.9); 2033 $163.74 (ROI 287); 2034 $173.96 (ROI 311.2); 2035 $185.19 (ROI 337.7).
The trajectory continues to 2040 with an average of $337.31 (ROI 697.2) and to 2050 with an average of $702.41 (ROI 1560.2), all with bullish sentiment.
A major floor 22.4% below — a decisive break under it would weaken the trend.
The nearest floor, 6.4% below — buyers have tended to step in here.
The nearest ceiling, 6.0% above — a clean break opens room to run.
A major ceiling 12.2% above — clearing it would confirm fresh momentum.
Key GRDN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GRDN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $40.75 | Buy | $40.91 | Buy |
| MA 10 | $41.25 | Sell | $40.98 | Sell |
| MA 20 | $41.40 | Sell | $40.87 | Buy |
| MA 50 | $39.33 | Buy | $39.67 | Buy |
| MA 100 | $37.46 | Buy | $37.55 | Buy |
| MA 200 | $33.24 | Buy | $34.04 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.55 | Neutral |
| Stoch RSI (14) | 55.62 | Neutral |
| CCI (20) | -24.59 | Neutral |
| Williams %R (14) | -33.92 | Info |
| MACD (12,26,9) | -0.19 | Sell |
| ROC (12) | 4.52 | Buy |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 66.08 | Neutral |
| TRIX (15) | 0.20 | Buy |
| Awesome (5,34) | 0.07 | Buy |
| Ultimate (7,14,28) | 42.10 | Neutral |
| Momentum (10) | 2.08 | Buy |
| Aroon Osc (25) | -16.00 | Sell |
| Hull MA (9) | 40.40 | Buy |
| ADX (14) | 16.57 | Neutral |
| ATR (14) | 0.81 | Info |
The near-term technical picture is bullish. RSI14 is 40, suggesting limited downside momentum at the moment.
The price is above the SMA50 of $38.51 and well above the SMA200 of $32.57, indicating constructive near-term price action. Support sits at $35.67 and resistance at $43.40, framing a 30-day range of $37.15 to $48.18.
Annualized volatility is 40%, underscoring elevated but not extreme swings in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $27.03 | $40.96 | $57.43 | 0% | Neutral | |
| $47.02 | $58.19 | $75.75 | +42% | Bullish | |
| $57.46 | $72.76 | $97.77 | +78% | Bullish | |
| $60.94 | $78.65 | $108.35 | +92% | Bullish | |
| $69.65 | $91.41 | $128.61 | +123% | Bullish | |
| $84.80 | $112.99 | $161.93 | +176% | Bullish | |
| $103.58 | $139.97 | $203.95 | +242% | Bullish | |
| $123.36 | $168.90 | $249.83 | +312% | Bullish | |
| $131.23 | $181.93 | $272.86 | +344% | Bullish | |
| $138.82 | $194.76 | $295.89 | +375% | Bullish | |
| $246.11 | $364.23 | $584.27 | +789% | Bullish | |
| $475.01 | $769.42 | $1,336.84 | +17.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $27.03 | $40.96 | $50.32 | +0.00% |
| August 2026 | $36.67 | $43.10 | $51.89 | +5.22% |
| September 2026 | $36.59 | $43.26 | $52.57 | +0.39% |
| October 2026 | $37.71 | $44.81 | $54.89 | +3.57% |
| November 2026 | $38.72 | $46.20 | $56.96 | +3.10% |
| December 2026 | $38.64 | $46.29 | $57.43 | +0.20% |
Click any year to see its month-by-month GRDN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Guardian Pharmacy Services, Inc.'s 2026 outlook centres on $40.96, within a $27.03 to $57.43 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, GRDN could reach as high as $75.75, with a base case around $58.19 and support toward $47.02 — roughly +42% from $40.96. Buyers look set to stay in control over this stretch.
Expect GRDN to range from $57.46 to $97.77 through 2028. The $72.76 average target implies a +78% move from current prices. That is up +25% on the projected 2027 average. Momentum favours further upside here.
The GRDN price prediction for 2029 points to an average of $78.65 (low $60.94, high $108.35) — a potential gain of +92% on today's $40.96. Buyers look set to stay in control over this stretch.
In 2030, GRDN is projected to trade between $69.65 and $128.61, averaging $91.41 — a potential gain of +123% from today's $40.96. That is up +16% on the projected 2029 average. Momentum favours further upside here.
Guardian Pharmacy Services, Inc.'s 2031 outlook centres on $112.99, within a $84.80 to $161.93 range. That is up +24% on the projected 2030 average. That marks a +176% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, GRDN could reach as high as $203.95, with a base case around $139.97 and support toward $103.58 — roughly +242% from $40.96. Momentum favours further upside here.
Expect GRDN to range from $123.36 to $249.83 through 2033. The $168.90 average target implies a +312% move from current prices. That is up +21% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The GRDN price prediction for 2034 points to an average of $181.93 (low $131.23, high $272.86) — a potential gain of +344% on today's $40.96. Momentum favours further upside here.
In 2035, GRDN is projected to trade between $138.82 and $295.89, averaging $194.76 — a potential gain of +375% from today's $40.96. That is up +7% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Guardian Pharmacy Services, Inc.'s 2040 outlook centres on $364.23, within a $246.11 to $584.27 range. That is up +87% on the projected 2035 average. That marks a +789% change versus current levels. Momentum favours further upside here.
By 2050, GRDN could reach as high as $1,336.84, with a base case around $769.42 and support toward $475.01 — roughly +17.8x from $40.96. Buyers look set to stay in control over this stretch.
Investing $1,000 in GRDN today (≈ 24.414063 GRDN) could be worth
$18,784.63
+$17,784.63 (+1778%) by 2050 · US Dollar
Based on the average projected GRDN price of $769.42 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GRDNwould be worth at today's price.
$1,000 invested in GRDN on Jul 10, 2025 (≈ 47.984645 GRDN) would be worth
$1,965.45
+$965.45 (+96.5%) today · 1.97× · US Dollar
Based on a GRDN entry price of $20.84 vs. today's $40.96.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $42 | $975.24 | -2.5% |
| 1 month ago | $41.97 | $975.94 | -2.4% |
| 3 months ago | $39.15 | $1,046.23 | +4.6% |
| 6 months ago | $31.51 | $1,299.9 | +30.0% |
| 1 year ago | $20.84 | $1,965.45 | +96.5% |
| All time (1.8y) ago | $16 | $2,560 | +156.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GRDN forecast.
Our base-case forecast reaches $82.00 around 2030.
Implied market cap at $82.00: $4.08B
The multi-year forecast shows a strong bullish trajectory. By 2030 the average price is $91.57, with a min of $71.11 and a max of $125.77; ROI is 116.4 and sentiment is bullish.
By 2040 the average price is $337.31, with a min of $236.95 and a max of $520.43; ROI is 697.2 and sentiment is bullish.
By 2050 the average price is $702.41, with a min of $458.18 and a max of $1,164.33; ROI is 1560.2 and sentiment is bullish.
These are estimates and not guarantees. Outcomes depend on market conditions and other factors not specified here.
Tap a question to reveal the answer.
The forecast shows a min of $71.11, an average of $91.57, and a max of $125.77, with ROI 116.4 and bullish sentiment.
Forecasts show bullish sentiment from 2027 onward with rising averages and ROI. For example, 2030 average is $91.57 (ROI 116.4), 2040 average is $337.31 (ROI 697.2), and 2050 average is $702.41 (ROI 1560.2).
Yes. The 2030 forecast lists a max of $125.77 and an average of $91.57, with 2031 at $111.33 on average, indicating the potential to exceed $100 within the forecast horizon.
Current price is $42.31 and market cap is $2.68B.
The 30-day range is $37.15 to $48.18, with support at $35.67 and resistance at $43.40. RSI14 is 40, SMA50 is $38.51, SMA200 is $32.57, and sentiment is BULLISH.
Guardian Pharmacy Services, Inc. Community Discussion
0Share your Guardian Pharmacy Services, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.